Pei-mei Chai
Linkou Branch, Taoyuan 333
Taoyuan, TNQ, Taiwan
Taoyuan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis.
Journal: Cancers
Published: September 17, 2024
Does autoimmune disease impair the survival of hepatocellular carcinoma patients undergoing liver resection? A multi-institutional observational study.
Journal: Journal of cancer research and clinical oncology
Published: March 25, 2024
Locoregional treatment improves overall survival for liver cancer during second-line regorafenib or immune checkpoint inhibitor.
Journal: American journal of cancer research
Published: December 25, 2023
Concurrent Atezolizumab Plus Bevacizumab and High-Dose External Beam Radiotherapy for Highly Advanced Hepatocellular Carcinoma.
Journal: The oncologist
Published: November 23, 2023
Significance of Physical Status and Liver Function Reserve for Outcome of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib Treatment.
Journal: Journal of hepatocellular carcinoma
Published: October 18, 2022
Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma.
Journal: Biomedicines
Published: July 30, 2022
Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first-line treatment for unresectable hepatocellular carcinoma.
Journal: Cancer medicine
Published: June 13, 2022
Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization.
Journal: Diagnostics (Basel, Switzerland)
Published: January 25, 2022
Combination of CRAFITY score with Alpha-fetoprotein response predicts a favorable outcome of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Journal: American journal of cancer research
Published: January 14, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026